Robert Donga

Title: Innovations by Robert Donga in Drug Dosage Forms

Introduction

Robert Donga is an accomplished inventor based in St-Hubert, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug dosage forms. With a total of 2 patents to his name, Donga's work focuses on enhancing the delivery and effectiveness of therapeutic agents.

Latest Patents

Donga's latest patents include a process for preparing a rapidly dispersing solid drug dosage form. This innovative dosage form consists of a water-insoluble compound that exists as a nanometer or micrometer particulate solid. The solid is surface stabilized by at least one phospholipid and is dispersed throughout a bulking matrix. When introduced into an aqueous environment, the bulking matrix dissolves within less than 2 minutes, releasing the water-insoluble particulate solid in an unaggregated state. The matrix is composed of a water-insoluble substance or therapeutically useful water-insoluble or poorly water-soluble compound, along with a phospholipid and optionally a surfactant. The volume-weighted mean particle size of the water-insoluble particle is 5 micrometers or less.

Career Highlights

Robert Donga is currently employed at Jagotec AG, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug delivery systems and enhancing patient outcomes.

Collaborations

Donga collaborates with notable colleagues, including Indu Parikh and Awadhesh K Mishra, who contribute to his research and development efforts.

Conclusion

Robert Donga's contributions to the field of drug dosage forms exemplify the importance of innovation in pharmaceuticals. His patents reflect a dedication to improving therapeutic delivery systems, ultimately benefiting patients worldwide.